[
	{
		"Metric": "Total_Assets",
		"2022": "48,983",
		"2023": "46,132",
		"2024": null
	},
	{
		"Metric": "Current_Assets",
		"2022": "547",
		"2023": "12,515",
		"2024": null
	},
	{
		"Metric": "Inventory",
		"2022": "2,339",
		"2023": "2,510",
		"2024": "2,632"
	},
	{
		"Metric": "Cash",
		"2022": "2,345",
		"2023": "2,465",
		"2024": "346"
	},
	{
		"Metric": "Marketable_Securities",
		"2022": "2,076",
		"2023": "1,628",
		"2024": "889"
	},
	{
		"Metric": "Accounts_Receivable",
		"2022": "1,263",
		"2023": "1,315",
		"2024": "576"
	},
	{
		"Metric": "Accounts_Payable",
		"2022": "9,234",
		"2023": "9,818",
		"2024": "(81)"
	},
	{
		"Metric": "Total_Liabilities",
		"2022": "33,693",
		"2023": "33,888",
		"2024": null
	},
	{
		"Metric": "Current_Liabilities",
		"2022": "9,181",
		"2023": "9,818",
		"2024": null
	},
	{
		"Metric": "Total_Debt",
		"2022": "7,399",
		"2023": "7,351",
		"2024": "(7,219)"
	},
	{
		"Metric": "Shareholders_Equity",
		"2022": "14,695",
		"2023": "12,230",
		"2024": null
	},
	{
		"Metric": "Revenue_a_k_a_Sales",
		"2022": "61,344",
		"2023": "65,762",
		"2024": "£68,187m"
	},
	{
		"Metric": "Cost_of_Goods_Sold_COGS",
		"2022": "45,136",
		"2023": "48,822",
		"2024": "(62,836)"
	},
	{
		"Metric": "Operating_Income_EBIT",
		"2022": "2,560",
		"2023": "2,509",
		"2024": "2,821"
	},
	{
		"Metric": "EBITDA",
		"2022": null,
		"2023": "4,057",
		"2024": "4,362"
	},
	{
		"Metric": "Net_Income",
		"2022": "1,483",
		"2023": "2,064",
		"2024": "1,192"
	},
	{
		"Metric": "Operating_Expenses_and_sub_items_SG_A_Advertising_R_D",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Interest_Expense",
		"2022": "650",
		"2023": "373",
		"2024": "373"
	},
	{
		"Metric": "Interest_Income",
		"2022": "9",
		"2023": "85",
		"2024": "94"
	},
	{
		"Metric": "Lease_Expense",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Depreciation",
		"2022": "£1,577m",
		"2023": "1,700",
		"2024": "899"
	},
	{
		"Metric": "Amortization",
		"2022": null,
		"2023": "278",
		"2024": "280"
	},
	{
		"Metric": "Capital_Expenditures_Capex",
		"2022": "£1.1bn",
		"2023": "1,235",
		"2024": "1,314"
	},
	{
		"Metric": "Operating_Cash_Flow",
		"2022": "£4.5bn",
		"2023": "3,722",
		"2024": "162"
	},
	{
		"Metric": "Net_Patient_Revenue",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Net_Operating_Income_NOI",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Rental_Revenue",
		"2022": "90",
		"2023": "90",
		"2024": "96"
	},
	{
		"Metric": "Order_Backlog",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Work_in_Progress",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Total_Contract_Value",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Retention_Receivables",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Contract_Revenue",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Reserves_Added",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Reserves_Extracted_Produced",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Total_Production",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Production_Transport_Costs",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Barrels_Produced",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Loan_Amount",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Collateral_Value_Property_Value",
		"2022": null,
		"2023": null,
		"2024": "£16.9bn"
	},
	{
		"Metric": "Debt_Service_Principal_Interest_Payments",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Annual_Admissions",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Average_Number_of_Beds",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Operating_Expenses_ex_Depreciation",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Earning_Assets",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Average_Earning_Assets",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Loan_Loss_Provisions",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Total_Loans",
		"2022": "6,490",
		"2023": "7,081",
		"2024": null
	},
	{
		"Metric": "Leased_Space",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Total_Available_Space",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Average_Subscribers",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Total_Service_Revenue",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Subscribers_at_Start_End_of_Period",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Customers_at_Start_End_of_Period",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Annual_Recurring_Revenue_ARR",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Number_of_Transactions",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Foot_Traffic",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Sales_for_Stores_Open_gt_1_Year",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Physical_Inventory_Count",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Recorded_Inventory",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Number_of_Drug_Trials_Total_and_Successful",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Sales_from_Patent_Protected_Drugs",
		"2022": null,
		"2023": null,
		"2024": null
	},
	{
		"Metric": "Market_Value_of_Equity_MVE",
		"2022": null,
		"2023": null,
		"2024": null
	}
]